Literature DB >> 18981537

Overexpression of P-glycoprotein in L1210/VCR cells is associated with changes in several endoplasmic reticulum proteins that may be partially responsible for the lack of thapsigargin sensitivity.

M Seres1, E Poláková, O Krizanová, S Hudecová, S V Klymenko, A Breier, Z Sulová.   

Abstract

L1210/VCR cells, which express an abundant amount of P-glycoprotein (P-gp), were found to be resistant to thapsigargin--an inhibitor of sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase (SERCA). In the current paper, we have studied the possible differences among L1210 and L1210/VCR cells in expression of endoplasmic reticulum proteins involved in the regulation of calcium homeostasis and calcium-dependent processes. Amounts of mRNA encoding both calcium release channels (ryanodine receptor channels--RyR and IP3-receptor channels--IP3R) were found to be at similar levels in sensitive and resistant cells. However, mRNAs encoding IP3R1 or 2 were decreased in resistant cells cultivated in the presence of VCR (1.08 micromol/l), while mRNA encoding RyR remained unchanged. The amount of mRNA for SERCA2 was decreased in resistant cells when compared with sensitive cells. This decrease was more pronounced when resistant cells were cultivated in the presence of vincristine (VCR). Calnexin was found to be less expressed at the protein level in resistant as in sensitive cells. The level of mRNA encoding calnexin was decreased only when resistant cells were cultivated in the presence of VCR. Calnexin was found to be associated with immature P-gp in resistant cells. Thus, differences exist between sensitive and resistant cells in the expression of endoplasmic reticulum proteins involved in the control of intracellular calcium homeostasis or calcium-dependent processes. These changes may be at least partially responsible for the lack of sensitivity of resistant cells to thapsigargin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981537

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  5 in total

1.  Metabolic Reprogramming During Multidrug Resistance in Leukemias.

Authors:  Raphael Silveira Vidal; Julia Quarti; Mariana Figueiredo Rodrigues; Franklin D Rumjanek; Vivian M Rumjanek
Journal:  Front Oncol       Date:  2018-04-04       Impact factor: 6.244

Review 2.  The Roles of microRNAs in Cancer Multidrug Resistance.

Authors:  Lucia Pavlíková; Mário Šereš; Albert Breier; Zdena Sulová
Journal:  Cancers (Basel)       Date:  2022-02-21       Impact factor: 6.639

3.  Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells.

Authors:  Tomáš Kyca; Lucia Pavlíková; Viera Boháčová; Anton Mišák; Alexandra Poturnayová; Albert Breier; Zdena Sulová; Mário Šereš
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

4.  Development of Resistance to Endoplasmic Reticulum Stress-Inducing Agents in Mouse Leukemic L1210 Cells.

Authors:  Martin Cagala; Lucia Pavlikova; Mario Seres; Karolina Kadlecikova; Albert Breier; Zdena Sulova
Journal:  Molecules       Date:  2020-05-28       Impact factor: 4.411

5.  Overexpression of GRP78/BiP in P-Glycoprotein-Positive L1210 Cells is Responsible for Altered Response of Cells to Tunicamycin as a Stressor of the Endoplasmic Reticulum.

Authors:  Mário Šereš; Lucia Pavlíková; Viera Boháčová; Tomáš Kyca; Ivana Borovská; Boris Lakatoš; Albert Breier; Zdena Sulová
Journal:  Cells       Date:  2020-04-06       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.